This course is designed to educate ophthalmologists on the fundamentals of optimizing outcomes in presbyopia-correcting IOL patients. In this course, faculty will discuss how materials and other IOL parameters elevate quality of vision. Faculty will also review recommendations for minimizing postoperative refractive errors to maximize patient satisfaction.
Supported by unrestricted education grants from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.Mastering the Fundamentals of Presbyopia-Correcting IOLs: Minimizing Postoperative Refractive Errors and Elevating Quality of Vision by Optimizing Materials
Media formats available:
Details
Presenters
Learning Objectives
Upon completion of this activity, the participant should be able to: - Review the impact of residual error on visual quality, acuity, and patient satisfaction.
- Reveal sources of residual error with presbyopia-correcting IOL patients and approaches to mitigate and/or resolve residual error.
Accreditation
Jointly Provided by Evolve Medical Education and The Fundingsland Group 
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education, LLC, and The Fundingsland Group. Evolve Medical Education, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Evolve Medical Education, LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers: Internet Explorer 11 for Windows Edge (recent versions; Chromium-based) for Windows Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements: 4GB+ RAM
Recommended internet speed 5Mbps+
Faculty and Disclosures
Douglas D. Koch, MD
Professor
Allen, Mosbacher, and Law Chair in Ophthalmology
Baylor College of Medicine
Houston, TX
Daniel H. Chang, MD
Cataract and Refractive Surgeon / Managing Partner
Empire Eye and Laser Center
Bakersfield, CA
Cathleen M. McCabe, MD
Chief Medical Officer, Eye Health America
Medical Director, The Eye Associates
Bradenton, FLDISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.The following faculty/staff members have the following financial relationships with commercial interests:
Douglas D. Koch, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Carl Zeiss Meditec, Johnson & Johnson Vision, and Perfect Lens. Stock/Shareholder: Ivantis, and Vivior.
Daniel H. Chang, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, Mynosys, and Omega Ophthalmics. Grant/Research Support: Acufocus, Johnson & Johnson Vision, and Mynosys. Stock/Shareholder: Omega Ophthalmics.
Cathleen M. McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Eye Point Pharmaceuticals, Ocular Therapeutix, Novartis, Dompé, Bausch + Lomb, Ivantis, Omeros,
and Sight Sciences. Grant/Research Support: Alcon Vision, Allergan, Dompé, Eye Point Pharmaceuticals, Glaukos, Johnson & Johnson Vision,
Ocular Therapeutix, Ivantis, and Novartis. Speakers List: Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Eye Point Pharmaceuticals, Ivantis, Novartis, Ocular Therapeutix, Omeros, and Sight Sciences. Stock/Shareholder: Engage Technologies and Ivantis.DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity. The following faculty/staff members have the following financial relationships with commercial interests:Douglas D. Koch, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Carl Zeiss Meditec, Johnson & Johnson Vision, and Perfect Lens. Stock/Shareholder: Ivantis, and Vivior. Daniel H. Chang, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, Mynosys, and Omega Ophthalmics. Grant/Research Support: Acufocus, Johnson & Johnson Vision, and Mynosys. Stock/Shareholder: Omega Ophthalmics. Cathleen McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant and Speaker’s Bureau: Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompe, Eye Point Pharma, Ivantis, Novartis, Ocular Therapeutix, Omeros, and Sight Sciences. Grant/Research Support: Alcon Vision, Allergan, Dompe, Eye Point Pharma, Glaukos, Ivantis, Johnson & Johnson Vision, Novartis, and Ocular Therapeutix. The Evolve Medical Education and The Fundingsland Group staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
Douglas D. Koch, MD
Moderator Professor and Allen, Mosbacher, and Law Chair in Ophthalmology Baylor College of Medicine Houston, TX
Daniel H. Chang, MD
Cataract and Refractive Surgeon / Managing Partner Empire Eye and Laser Center Bakersfield, CA
Cathleen M. McCabe, MD
Chief Medical Officer, Eye Health America Medical Director, The Eye Associates Bradenton, FL
Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, or Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals. System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Eric D. Donnenfeld, MD
Marjan Farid, MD
Jason J. Jones, MD
Eva I. Liang, MD, FACS
Carlton Yuen, MD
Jennifer, I. Lim, MD, FASRS, FARVO
Jeremiah Brown Jr., MD, MS, FASRS
Rahul N. Khurana, MD, FASRS
Andrew R. Harrison, MD
Kian Eftekhari, MD
Andrew G. Lee, MD
Wendy W. Lee, MD
Nicholas Robert Mahoney, MD
Amina Malik, MD
Prem S. Subramanian, MD, PhD
Jeremiah Tao, MD, FACS
Blake K. Williamson, MD, MPH, MS
Brett Mueller, DO, PhD
Taj Nasser, MD
Julie Marie Schallhorn, MD, MS
Evan D. Schoenberg, MD
F. Beau Swann, MD, MS
Rahul S. Tonk, MD, MBA
William F. Wiley, MD
